GTAC (MND) Study now recruiting patients in Scotland.

New MND Study - GTAC (Genomic Translation for ALS Clinical Care) Study

The GTAC MND study is an international observational study, led by the University of Columbia in the USA. The study will investigate why a person develops motor neurone disease (MND) and why their symptoms present and progress with particular patterns.

Researchers will gather information about the health, environmental exposures, and follow the pattern/progression of the disease over time in individuals. This information will be used together with genetic information from blood samples to look for factors that determine why motor neurone degeneration begins and how or why it progresses.

The study will also store cells from blood samples that can be used in future studies.

We hope to recruit 50 people from Scotland into the GTAC study. This involves a one off visit to Edinburgh to have a neurological examination, questionnaires and a blood sample taken. Follow-up is 3-6 after the initial visit and this can be conducted over the phone by the research team. 

For further information about the study including exclusion criteria please contact Judith Newton, Scottish MND National Lead Consultant Nurse or register your interest at CARE-MND and one of our research team will contact you.